Drug intelligence / Profile preview

Neonervin

Development stage
Unknown
Lead developer
Grand Medical Group
Modality
Small Molecules
Administration
Oral
01

Overview

Neonervin is an oral dietary supplement developed by Grand Medical Group, formulated as capsules and an oral solution. It is designed to support cardiovascular and neurological health, specifically targeting peripheral nerve damage, neuropathic pain, paresis, and cognitive decline. Neonervin contains a combination of active ingredients, including alpha-lipoic acid (an antioxidant that protects blood vessels and peripheral nerves), cytidine-5-monophosphate (CMP) disodium and uridine 5′-triphosphate (UTP) trisodium (nucleotides that activate P2Y receptors to promote myelin sheath regeneration and synaptogenesis), meclofenoxate (a cholinergic nootropic that increases acetylcholine levels and clears lipofuscin), and magnesium L-threonate (a highly bioavailable form of magnesium that crosses the blood-brain barrier to enhance synaptic density and cognitive function).

Brand names
Neonervin
02

Targets

P2RY2 (P2Y Purinoceptor 2)NMDAR (Glutamate receptor ionotropic, NMDA)

Beyond the preview

Go deeper on Neonervin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neonervin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call